Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure (Q41212897)

28 September 2017

title

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure (English)

1 reference

sexually transmitted infection

28 September 2017

0 references

0 references

0 references

author name string

Paxton WA

1

1 reference

28 September 2017

Martin SR

2

1 reference

28 September 2017

Tse D

3

1 reference

28 September 2017

O'Brien TR

4

1 reference

28 September 2017

Skurnick J

5

1 reference

28 September 2017

VanDevanter NL

6

1 reference

28 September 2017

Padian N

7

1 reference

28 September 2017

Braun JF

8

1 reference

28 September 2017

Kotler DP

9

1 reference

28 September 2017

Wolinsky SM

10

1 reference

28 September 2017

Koup RA

11

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

2

1 reference

28 September 2017

issue

4

1 reference

28 September 2017

page(s)

412-417

1 reference

A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Humans with OKT4-epitope deficiency have a single nucleotide base change in the CD4 gene, resulting in substitution of TRP240 for ARG240.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

Infectiousness of HIV between male homosexual partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Genetic risk factors for perinatally acquired HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

CD8+ cell anti-HIV activity: nonlytic suppression of virus replication

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Possible association of CD3 and CD4 polymorphisms with insulin-dependent diabetes mellitus (IDDM)

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-412

7 January 2021

Identifiers

DOI

10.1038/NM0496-412

1 reference

28 September 2017

1 reference